This study greatly enhances our knowledge of the role played by the MET pathway in uveal melanoma cells, with new information proposing the combination treatment of small molecule MEK and MET inhibitors in cells harboring G-alpha protein gene mutations. Here, MAP2K7 is linked to uveal melanoma.